|
Thursday,
March 29th |
|
To register for the Immunization
Training Program, pharmacists should use the
Senior Symposium online registration form
and pay a fee of $249.
A
separate fee is required if you also want to
attend the Senior Symposium program
|
 9:00am
- 3:00 pm -
Immunization Training for
Pharmacists
To view
Immunization Program Brochure
[Click
Here]This comprehensive practice-based
continuing pharmacy education
program is designed to meet state
regulations for pharmacist
immunizers and prepare you for the
immunization season. 10 hours
of home study continuing education
must be completed prior to this live
session. Full details can be
found at
www.pharmacyce.uconn.edu (click
on the Immunization tab in the upper
banner)
 The
University of Connecticut,
School of Pharmacy, is
accredited by the Accreditation
Council for Pharmacy Education
as a provider of continuing
pharmacy education and will
award a total of 1.5 CEUs (15
contact hours) for pharmacists
who successfully complete with a
70% passing grade on all post
tests for the online content,
present all statements of
completion for the online
content, participate in the live
session, pass the workshop
requirements and practical exam
and complete a course
evaluation. One knowledge-based
contact hour or 0.10 CEU (ACPE
#009-000-09-035-L03-P), will
apply to law, ten
knowledge-based contact hours or
1.0 CEUs (ACPE
#009-000-09-036-H01-P) and four
application-based contact hours
(ACPE # 009-000-09-037-L04-P)
will be awarded. A
Practice-based Certificate of
Achievement will be presented
following successful completion
of all requirements.
Registration &
Program Location:
Grand Pequot Tower - Sun
Valley - 10th Floor
Speakers:
Thomas Buckley,
B.S., M.P.H, Jennifer Girotto,
Pharm.D., BCPS, Jill Fitzgerald,
PharmD,
Lauren S. Schlesselman, Pharm.D
Learning Objectives:
At the end of the activities,
pharmacists will be able to:Describe
passive and active immunity
• Describe the types
of live and inactive vaccines
• List disease states
or patient characteristics for which
live vaccines are contraindicated
• Describe differences
between conjugate and polysaccharide
vaccines
• List vaccines
currently recommended in the
pediatric and adult routine
vaccination schedules and their
mechanism
of action, contraindications, precautions, drug interactions and
monitoring after administration
• Describe the diseases
that each vaccines in the schedules
prevent
• Explain the impact
of vaccination on public health
• Identify community
resources and immunization
coalitions available in your
community
• Describe the
pharmacist’s role as an immunizer
• Describe
Occupational Safety and Heath
Administration (OSHA) regulations to
protect employees from blood-borne
pathogens
• Recall proper
biohazard waste disposal and sterile
techniques
• List common and
known serious adverse events from
vaccines in the current schedules
• Describe what
Vaccine Adverse Event Reporting
System (VAERS) is and the mechanism
to report adverse events
• Demonstrate how to
give a subcutaneous and
intramuscular injection
• Describe the proper
immunization screening, vaccine
information sheets, informed
consent, record keeping and
registries pharmacists would use in an immunization program
• Identify storage
requirements for vaccines
• Apply current
vaccine schedules to specific
patient cases
• Design a “catch-up”
schedule for specific patient case
scenarios
• Explain current
reimbursement procedures and vaccine
coverage by federal, state and local
entities
• Describe the current
state laws governing the administration of vaccines by pharmacists
|
Senior Symposium 2012 Program
12:00
noon Program Registration
Opens - Pequot
Ballroom Pre-function |
Mini-Rounds
1:45
pm
- 3:45 pm
1.
Mini-Rounds: Off-label Use pf
Atypical Antipsychotics
ACPE#:
0203-9999-12-012-L01-P
-
0.5 CEU )(.05
contact hour) - Knowledge-based CE
Location:
Pequot
D & E
Speaker:
Tomas R.
Clark, RPh, MHS
Learning Objectives:
At the end of the activities,
pharmacists will be able to:
•
Discuss the prevalence and legal
implications of off-label use of
prescription medications
•
Describe the rationale and
appropriateness of off-label use of
atypical antipsychotics
Session
Handout
[Click Here]
2.
Mini-Rounds: STOPP, what’s that
sound? Everyone look: a new Beers is
coming ‘round!
Identifying potentially inappropriate medications in the
elderly
ACPE#:
0203-9999-12-006-L01-P
-
0.5 CEU )(.05
contact hour) - Application-based CE
Location:
Pequot
D & E
Speaker:
Stephanie
Hattoy, PharmD
Learning Objectives:
At the end of the activities,
pharmacists will be able to:
•
Discuss the proposed updates and
changes to the American Geriatric
Society Beers’ Criteria for
Potentially
Inappropriate Medication Use in Older Adults
• Compare methods for assessing
inappropriate medication use in the
elderly including the START and
STOPP criteria
Session
Handout
[Click Here]
3.
Mini-Rounds: How about becoming a
Hospice Volunteer?
ACPE#:
0203-9999-12-007-L04-P
-
0.5 CEU)(.05
contact hour) - Knowledge-based CE
Location:
Pequot
D & E
Speaker:
Robert Tendler, RPh
Learning Objectives:
At the end of the activities,
pharmacists will be able to:
•
Discuss the facts behind Hospice
•
Discuss
how to become a hospice consultant
pharmacist
4.
Mini-Rounds: Time to Smile-A
Practical Discussion Relating
Medication Usage
and Dental Concerns for the Senior Patient
ACPE#:
0203-9999-12-005-L01-P - 0.5
CEU (.05 contact hour) -
Knowledge-based CE
Location:
Pequot
D & E
Speaker: Cynthia Enright,
PharmD
Learning Objectives: At the
end of the activities, pharmacists
will be able to:
• Discuss the relationship between
oral care and medications from the
pharmacist’s perspective
• Define the ADA Guidelines for
prophylactic antibiotic usage for
infective endocarditis
Session
Handout [Click
Here]
|
4:00 pm
- 5:00 pm
Hepatitis C Virus Infection in the
HIV/AIDS and Elderly Population
ACPE#:
0203-9999-12-009-L02-P
-
0.1 CEU )(1
contact hour) - Knowledge-based CE
Location:
Pequot
D & E
Speaker: Zane Saul,
MD
Learning Objectives:
At the
end of the activities, pharmacists
will be able to:
• Describe the epidemiology of
chronic hepatitis C virus infection
in the older population
• Outline the course of hepatitis C
virus and with emphasis in older
adults
• Recognize the importance of screening, early intervention, and
disease monitoring
•
Explain current guidelines for
treatment and management of chronic
hepatitis C in the older adult
population
Session
Handout [Click
Here]
|
5:00
pm - 6:30 pm
Dinner Product
Theater
Topic: Rheumatoid Arthritis in the
Primary Care Setting
ACPE#:
This is a
non-CE event supported by Abbott
Location: Pequot
A & B
Speaker:
Christopher F. Mojcik, MD, PhD |
6:30
pm - 8:00 pm
New
Drugs Update 2012
ACPE#:
0203-9999-12-010-L01-P
-
0.15 CEU )(1.5
contact hours) -
Knowledge-based CE
Location:
Pequot A & B
Speaker: Tom Frank, PharmD
Learning objectives -
At the
end of the activities, pharmacists
will be able to:
•
Assess new trends in drug
development
•
Understand indications,
pharmacology, adverse effects and
dosing of the products discussed
•
Determine the role these products
will play in the participant’s
practice
•
Evaluate the economic implications
of these choices
•
Examine products in the short-term
pipeline that will be important to
the practice of the participants
Session
Handout
[Click
Here]
|
8:00
pm - 9:00 pm
Evening
Reception
Location:
Pequot Ballrom
Pre-function |
|
FRIDAY,
March 30th |
|
5:30am Registration
Opens - Location:
Pequot Ballroom
Pre-function |
6:00
am - 7:00 am
First Lite Symposium: Assessing the
Geriatric Patient with
Emphasis on Cognitive Testing and
Other geriatric Issues
ACPE #: 0203-9999-12-011-L01-P
-
0.1 CEU )(1
contact hour)
Knowledge-based CE
Location: Pequot
A & B
Speaker: Phil
Wizwer, MS
Learning Objectives:
At the
end of the activities, pharmacists
will be able to:
•
Identify why it is important for
pharmacist to be able to assess the
cognitive function of older
individuals
•
Identify and be able to utilize
various tools that may be used to
assess cognitive function of the
older individual
Session
Handout
[Click
Here]
|
7:00
am - 8:15 am
Breakfast Product Theater
Optimizing the Management of COPD
in Long-Term Care
Twice-daily Nebulization
Can Make a Difference in Certain
Residents
ACPE# : This is a non-CE Event
- Supported by DEY Pharma, L.P.
Location: Pequot
D
Speaker: Manual
Suarez-Barcelo MD, CMD |
7:00
am - 8:15 am
Breakfast Product Theater
Topic: Optimizing Pain
Therapy Outcomes in Long-Term Care
fro Healthcare Professionals
ACPE# : This is a non-CE Event
- Supported by Endo
Pharmaceuticals
Location: Pequot
E
Speaker: Heather
Thomson, MBA, MS |
8:30
am - 10:00 am
Opening
General Session
LAW CE:
Independence vs. Liabilty: How and
When to Take the Keys
ACPE #: 0203-9999-12-009-L03-P
0.15 CEU )(1.5
contact hours)
Knowledge-based CE
Locations: Pequot
A & B
Speaker: Richard Marottoli, MD
Learning Objectives:
At the
end of the activities, pharmacists
will be able to:
• Recognize medical
factors that contribute to driving
safety/risk
• Discuss the
contribution of medications to
driving safety/risk
• Describe interventions
that may enhance safety
• Explain possible
approaches for raising the issue
with patients/families
• Describe the process of
DMV reporting
Session Handout
[Click
Here]
|
10:15
am - 11:15 am
Second General
Session - 9th Annual Timothy
Webster Memorial Address
Successful Aging: Strategies for a
Vital Future
ACPE #: 0203-9999-12-013-L01-P
- 0.1 CEU )(1
contact hour) Knowledge-based
CE
Locations:
Pequot
A & B
Speaker: Desmond
Ebanks, MDA
Learning Objectives:
At the
end of the activities, pharmacists
will be able to:
• Explain how to
improve quality of life now and into
the future
•
Identify the major risk factors for
premature death
• Describe the role that
telomeres play in aging and disease
Session Handout
[Click
Here]
|
11:30
am - 1:00 pm
Luncheon
|
11:30
am - 1:00 pm
Product Theater
Topic: Xarelto (Rivaroxaban)
for Reducing the Risk of Stroke and
Systemic Embolism in Patients with
Non-valvular Atrial
Fibrillation
ACPE# : This is a non-CE Event
- Supported by Johnson & Johnson
Healthcare Systems/Janssen
Pharmaceuticals, Inc.
Location: Pequot
D
Speaker: W. Vincent
Perrelli MD |
11:30
am - 1:00 pm
Product Theater
Topic: MDS 3.0 and the
Management of Moderate to Severe
Alzheimer's Disease in LTC
ACPE#:
This is a non-CE Event
- Supported by Forest
Pharmaceuticals, Inc.
Location:
Pequot
E
Speaker:
Roger
Cadieux, MD |
1:30
pm - 3:00 pm
General Session - LAW CE - Church
and State:
CMS
Regulations on Consulting and
Long-term Care Pharmacy
ACPE #: 0203-9999-12-007-L03-P
0.15 CEU )(1.5
contact hours/1.5Law) -
Knowledge-based CE
Location:
Pequot
A & B
Speaker:
Lynne Batshon
Learning
Objectives:
At the
end of the activities, pharmacists
will be able to:
•
Identify the
key components of the CMS regulatory
proposal for requiring consultant
pharmacist services to be
financially independent from certain business relationships
• Give examples of
circumstances under which conflicts
of interest may pose challenges to
the provision of consultant
pharmacist services to residents of long-term care facilities
•
Give examples of methods for
minimizing the potential for, or
appearance of, conflicts of interest
•
List and describe
ASCP’s top priority legislative and
regulatory agenda for 2012
•
Give examples of how pharmacists can
engage in activities at the local
level to advance the profession and
ASCP’s
advocacy agenda
Session Handout
[Click Here]
|
|
Breakout Sessions
-Select one in each time
period |
TRACK
1
3:15
pm - 4:15 pm
The Aging Kidney:
Implications for Drug Dosing
ACPE#
0203-9999-12-010-L01-P
0.10 CEU (1 contact hour)
Knowledge-based CE
Location:
Pequot D
Speaker: Rachel
Eyler, PharmD
Learning Objectives -
At the
end of the activities, pharmacists
will be able to:
• Describe the changes in
kidney structure and
function
that occur in elderly individuals
• Evaluate the usefulness
and limitations of equations
used to predict renal function in the elderly
• Incorporate assessments of
kidney function and clinical
picture into drug dosing decisions
Session Handout
[Click
Here]
|
TRACK 2
3:15
pm - 4:15 pm
COPD
Readmission Reduction
Strategies
ACPE#
0203-9999-12-013-L01-P
0.10 CEU (1 contact hour)
Knowledge-based CE
Location:
Pequot
E
Speaker: Kate
Wheeler, PharmD
Learning Objectives
-
At the
end of the activities, pharmacists
will be able to:
•
Identify the magnitude of
COPD as a healthcare problem
and identify opportunities for improvements in patient
care services
• Discuss potential
opportunities for
pharmacists and
interns to assist patients as they transition throughout
the healthcare system
• Explain how one
pharmacist-led transition
program
could be adapted to work in different settings
Session Handout
[Click
Here]
|
TRACK
1
4:30
pm - 5:30 pm
Adverse Drug Reactions in
the Elderly:
An Update for 2012
ACPE #
0203-9999-12-008-L01-P
0.10 CEU (1 contact hour)
Knowledge-based CE
Location:
Pequot D
Speakers: Dennis
Chapron, RPh, M.S.
Learning Objectives -
At the
end of the activities, pharmacists
will be able to:
• Discuss recent findings on
medication use by the
elderly
with implications for emergency department visits and
hospital admissions
• Review selected drug-drug
interactions and adverse
drug
effects with emphasis on prevention and monitoring
strategies
• Discuss adverse drug
reactions as a cause of bone
loss,
hyperkalemia, falls, urinary retention, gi bleeding, acute
renal failure, and altered mental status
Session Handout
[Click
Here]
|
TRACK 2
4:30
pm - 5:30 pm
Congestive
Heart Failure:
Transitions of Care
ACPE #
0203-9999-12-011-L01-P
0.10 CEU (1 contact hour)
Knowledge-based CE
Location:
Pequot E
Speakers:
Jason Ryan, MD
Learning Objectives -
At the
end of the activities, pharmacists
will be able to:
• Identify the
challenges for heart failure
patients at
discharge
•
Describe the UCONN program
to reduce heart failure
readmissions
•
Define the roles of
different healthcare
practitioners in
successful heart failure transitions of care
Session Handout
[Click
Here]
|
|
|
|
|
|
